139 related articles for article (PubMed ID: 34976241)
1. Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.
Kozłowska-Geller M; Głuszek S; Lewitowicz P
Prz Gastroenterol; 2021; 16(4):330-338. PubMed ID: 34976241
[TBL] [Abstract][Full Text] [Related]
2. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression.
Kozłowska-Geller MA; Lewitowicz P; Głuszek SZ
Pol J Pathol; 2021; 72(2):124-129. PubMed ID: 34706519
[TBL] [Abstract][Full Text] [Related]
3. P21 is not a prognostic marker for rectal cancer - five-year follow up study of rectal cancer in stages I-IV.
Kozłowska-Geller MA; Głuszek SZ; Lewitowicz P
Contemp Oncol (Pozn); 2020; 24(4):247-251. PubMed ID: 33531872
[TBL] [Abstract][Full Text] [Related]
4. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases.
Schwandner O; Bruch HP; Broll R
Eur Surg Res; 2002; 34(6):389-96. PubMed ID: 12403937
[TBL] [Abstract][Full Text] [Related]
6. Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM classification) primary lung cancer after curative surgery.
Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Adachi H; Miura J; Shigefuku S; Kikuchi A; Rino Y
Lung Cancer; 2021 Dec; 162():128-134. PubMed ID: 34775216
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
8. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
9. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
11. Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
Yang CC; Lin LC; Lin YW; Tian YF; Lin CY; Sheu MJ; Li CF; Tai MH
Oncol Lett; 2019 Feb; 17(2):1551-1558. PubMed ID: 30675212
[TBL] [Abstract][Full Text] [Related]
12. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study.
Schneider CP; Heigener D; Schott-von-Römer K; Gütz S; Laack E; Digel W; Guschall WR; Franke A; Bodenstein H; Schmidtgen C; Reck M
J Thorac Oncol; 2008 Dec; 3(12):1446-53. PubMed ID: 19057271
[TBL] [Abstract][Full Text] [Related]
14. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
[TBL] [Abstract][Full Text] [Related]
15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
16. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
[TBL] [Abstract][Full Text] [Related]
17. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
[TBL] [Abstract][Full Text] [Related]
18. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
